Follow
Wakako Kuribayashi
Wakako Kuribayashi
NIA/NIH
Verified email at nih.gov
Title
Cited by
Cited by
Year
Limited rejuvenation of aged hematopoietic stem cells in young bone marrow niche
W Kuribayashi, M Oshima, N Itokawa, S Koide, Y Nakajima-Takagi, ...
Journal of Experimental Medicine 218 (3), e20192283, 2020
572020
Epigenetic traits inscribed in chromatin accessibility in aged hematopoietic stem cells
N Itokawa, M Oshima, S Koide, N Takayama, W Kuribayashi, ...
Nature communications 13 (1), 2691, 2022
302022
DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes
K Kayamori, Y Nagai, C Zhong, S Kaito, D Shinoda, S Koide, ...
Blood advances 5 (2), 438-450, 2021
152021
Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias
M Poplineau, N Platet, A Mazuel, L Hérault, L N’guyen, S Koide, ...
Blood, The Journal of the American Society of Hematology 140 (22), 2358-2370, 2022
142022
Bmi1 restricts the adipogenic differentiation of bone marrow stromal cells to maintain the integrity of the hematopoietic stem cell niche
Y Kato, LB Hou, S Miyagi, E Nitta, K Aoyama, D Shinoda, S Yamazaki, ...
Experimental Hematology 76, 24-37, 2019
112019
Incomplete rejuvenation of aged HSCs in young bone marrow niche
W Kuribayashi, A Iwama, M Oshima
Experimental Hematology 76, S72, 2019
52019
Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model
W Kuribayashi, K Takizawa, K Sugata, M Kuramitsu, H Momose, E Sasaki, ...
Oncotarget 7 (32), 51027, 2016
52016
Single-cell multi-omics analyses reveal EZH2 as a main driver of retinoic acid resistance in PLZF-RARA leukemia
M Poplineau, N Platet, A Mazuel, L Hérault, S Koide, W Kuribayashi, ...
bioRxiv, 2022.01. 04.474890, 2022
2022
Single Cell Analyses Reveal a Non-Canonical EZH2 Activity As a Main Driver of Retinoic Acid Resistance in PLZF/Rara Leukemia
M Poplineau, N Platet, A Mazuel, L Hérault, S Koide, W Kuribayashi, ...
Blood 138 (Supplement 1), 2205-2205, 2021
2021
3115–INTEGRATIVE MULTI-OMICS ANALYSIS FOR UNDERSTANDING ACUTE PROMYELOCYTIC LEUKEMIA RESISTANCE: EZH2 ON THE ROAD
M Poplineau, L Hérault, A Mazuel, N Platet, S Koide, W Kuribayashi, ...
Experimental Hematology 100, S98, 2021
2021
3074–CHANGES IN CHROMATIN ACCESSIBILITY DURING HEMATOPOIETIC STEM CELL AGING
N Itokawa, A Iwama, S Koide, W Kuribayashi, M Oshima, N Takayama
Experimental Hematology 100, S78, 2021
2021
DEVELOPMENT OF HTLV-1 HYPERIMMUNE GLOBULINS AGAINST HTLV-1 INFECTION
T Mizukami, K Nojima, R Sobata, W Kuribayashi, C Matsumoto, Y Sato, ...
HAEMATOLOGICA 102, 140-140, 2017
2017
SAFETY AND EFFICACY OF HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) HYPERIMMUNE GLOBULIN AGAINST HTLV-1 INFECTION IN A HUMANIZED MOUSE MODEL
T Mizukami, K Nojima, W Kuribayashi, E Sasaki, M Kuramitsu, K Ohkuma, ...
HAEMATOLOGICA 101, 133-133, 2016
2016
Identification of ATL stem cells in an ATL model HBZ transgenic mouse
W Kuribayashi, T Mizukami, K Takizawa, K Sugata, M Kuramitsu, ...
Experimental Hematology 43 (9), S74, 2015
2015
IMMUNOGLOBULIN PROPHYLAXIS AGAINST HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I PREVENTS INFECTION IN A HUMANIZED MOUSE MODEL
T Mizukami, K Nojima, C Matsumoto, W Kuribayashi, R Sobata, ...
HAEMATOLOGICA 100, 139-139, 2015
2015
IDENTIFICATION OF LEUKEMIC STEM CELL CANDIDATES IN AN ATL MOUSE MODEL OF HBZ TRANSGENIC MICE
W Kuribayashi, T Mizukami, K Takizawa, K Sugata, M Kuramitsu, ...
HAEMATOLOGICA 100, 546-547, 2015
2015
The Osteoclast Targeting Therapy In Bone Metastasis For a Mouse Model Of Adult T Cell Leukemia
T Mizukami, K Takizawa, J Yamazaki, W Kuribayashi, M Kuramitsu, ...
Blood 122 (21), 3691, 2013
2013
THE ROLE OF OSTEOCLASTS IN THE DEVELOPING LEUKEMIC STEM CELL NICHE IN A MOUSE MODEL OF ADULT T-CELL LEUKEMIA
T Mizukami, K Takizawa, M Kuramitsu, W Kuribayashi, R Hiramatsu, ...
HAEMATOLOGICA 98, 494-494, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–18